|
Re: genetic differences may explain why some on AIs have worse joint point than other
I agree. As we learn more about how drugs interact with cancer, it would not surprise me to find that there is a continuum of possible reactions to any given drug for each particular patient, that ranges from a "cure" at one end of the spectrum to cancer promotion at the other end. Finding out where on the spectrum any particular patient will fall at any point in their treatment, based on their individual biology, will be the hard part.
Hopeful
|